Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...

Third-party companies known as pharmacy benefit managers, which administer prescription drug benefits for health insurance ...

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...

The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...

President Donald Trump’s firing this week of two Democratic members of the Federal Trade Commission calls into question how ...

Cigna’s Express Scripts and UnitedHealth Group’s OptumRx of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.” ...

The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.

Pharmacy benefit managers OptumRx and Express Scripts have asked the federal judge overseeing nationwide litigation over the ...